Harpoon Therapeutics

$5.69 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Harpoon Therapeutics

Harpoon Therapeutics, Inc. operates as a biotechnology company. The Company develops novel class T cell that unleash the natural power of the T cells to fight cancer and other diseases. Harpoon Therapeutics serves patients in the States of Massachusetts and California.

Stock Analysis

last close $5.69
1-mo return -12.9%
3-mo return -40.2%
avg daily vol. 268.43T
52-week high 25.24
52-week low 5.68
market cap. $216M
forward pe -
annual div. -
roe -154.7%
ltg forecast -
dividend yield -
annual rev. $27M
inst own. 78.5%

Subscribe now for daily local and international financial news